Healthcare has a habit of embracing patient empowerment right up until patients become powerful. The post From OpenNotes to “Doc Can I Record You?” Why Physicians Should Embrace Era of Accountability appeared first on MedCity News.
WINNER, Dakota del Sur — Sophie Hofeldt tenía previsto hacerse los controles de embarazo y dar a luz en el hospital local, a 10 minutos de su casa. En cambio, ahora, para ir a la consulta médica, tiene que conducir más de tres horas entre ida y vuelta. Es que el hospital donde se atendía,…
In a sit-down interview at the annual J.P. Morgan Healthcare conference, Allen talked about a tool built by a company backed by General Catalyst and Andreessen Horowitz. The post One Healthcare AI Application that Intrigues Intermountain Health’s CEO appeared first on MedCity News.
It’s a holy grail of health care: forcing the industry to reveal prices negotiated between health plans and hospitals — information that had long been treated as a trade secret. And among the flurry of executive orders President Donald Trump signed during his first five weeks back in office was a promise to “Make America…
Upside’s $20 million raise was led by Aquiline and Flare Capital Partners, with support from existing investors including 645 Ventures, Freestyle Capital, Triple Impact Capital and Techstars. The post Upside Seeks to Solve the Housing Crisis Armed with $20M Raise appeared first on MedCity News.
The private plans that offer the Medicare Part D benefit – stand-alone drug plans and Medicare Advantage drug plans – are increasingly are competing on uneven terms, in part because the payment system for Medicare Advantage plans enables them to lower Part D premiums or reduce Part D cost sharing, making drug coverage from Medicare…
Health system performance has splintered into three distinct groups — leaders, strugglers and those stuck in the middle, according to Fitch Ratings’ Kevin Holloran. At the HFMA Annual Conference, he and Mayo Clinic CFO Dennis Dahlen discussed how technology and innovation are accelerating this divide. The post The Hospital Word Has Become a Tale of…
RSNA24 showcased important progress in leveraging AI for multiple important purposes
Novartis already markets the PI3Kα inhibitor Piqray for breast cancer, but acquiring a Synnovation Therapeutics subsidiary brings an early clinical program that the pharma company claims could be best in the class of next-generation therapies for the target. Competitors include Eli Lilly, Relay Therapeutics, and OnKure Therapeutics. The post Why Novartis Is Paying $2B for…
Thyme Care’s Series E round was led by Morgan Health and included participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health. The post Thyme Care Raises $125M, Launches New Oncology Parent Entity appeared first on MedCity News.